secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2026-08-31T20:01:43+00:00
Accession:  0001493152-26-040814
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ENvue Medical announces 1-for-12 reverse stock split effective Sept 1, 2026
---------------------------------------------------------------------------

- Effective Sept 1, 2026 at 12:01 a.m. EDT; shares start trading split-adjusted on Nasdaq under FEED with new CUSIP 63008J876.
- Outstanding shares reduce from 11,084,616 to approximately 923,718; each 12 shares combine into 1.
- Authorized shares unchanged at 40,000,000; par value and preferred stock unaffected.
- No fractional shares; any fractional shares rounded up to nearest whole share per stockholder.
- Options, warrants, convertibles, and restricted stock adjusted by dividing share count by 12 and multiplying exercise price by 12.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315226040814/0001493152-26-040814-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315226040814/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-040814

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer